The cell therapy processing market was valued at USD 1,723 million in 2019, and is projected to reach USD 12,132 million by 2027, registering a CAGR of 28.2% from 2020 to 2027.
Cell therapy processing refers to administration of living cells in a patient’s body for treating a disease. For cell processing therapy, different types of cells can be utilized, including neural cells, skeletal muscle cells, embryonic stem cells, hematopoietic stem cells, and mesenchymal cells. Moreover, it is used for the treatment of cancers, repairmen of spinal cord injuries, infectious & urinary diseases, autoimmune diseases, improvement of a weakened immune system, rebuilding damaged cartilage in joints, and helping patients with neurological disorders.
Increase in the demand for chimeric antigen receptor (CAR) T cell therapy, rise in the R&D for the advancement in the research associated with cell therapy, rise in the incidence of cardiovascular diseases, rise in the potential of cell therapies in the treatment of diseases associated with lungs using stem cell therapies, and increase in a number of clinical studies relating to the development of cell therapy processing are the major factors that drive the growth of the cell therapy processing market. In addition, introduction of novel technologies for cell therapy processing, large number of oncology-oriented cell-based therapy clinical trials, increase in adoption of regenerative drug, rise in government investments for cell-based research, and increase in number of GMP-certified production facilities across the globe are further expected to propel the growth of the cell therapy processing market. However, high-costs associated with the cell therapies, and bottlenecks experienced by manufacturers during commercialization of cell therapies are expected to hinder the growth of the market. Furthermore, the emerging economies present lucrative opportunities for the market.
Cell Therapy Processing Market Segmentation
The cell therapy processing market is segmented into offering type, application, and region. By type, the market is categorized into products, services, and software. The application covered in the segment include cardiovascular devices, bone repair, neurological disorders, skeletal muscle repair, cancer, and others. On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
Based on offering type, the market is categorized into products, services, and software. At present, products segment dominates the cell therapy processing market, and is anticipated to continue this trend over the forecast period. The key factors that driving the market growth are rise in the incidence of cardiovascular diseases, increase in demand for cell therapy processing, surge in adoption of allogeneic cell therapy, and introduction of novel technologies for cell therapy processing are majorly driving the growth of this segment. Some of the major market players that offer cell therapy processing products are BioTime, Inc., Regeneus Ltd., Targazyme, Inc., Bone Therapeutics, NeuroGeneration, and Invitrx Therapeutics, Inc.
Based on application, the market is classified into cardiovascular devices, bone repair, neurological disorders, skeletal muscle repair, cancer, and others. The skeletal muscle repair is the major shareholder in the global cell therapy processing market owing to rise in incidence of skeletal muscle injury, rise in geriatric population, increase in prevalence of chronic diseases, increase in usage of regenerative medicine, and increase in adoption of minimally invasive surgeries.
Snapshot of Asia-Pacific cell therapy processing market
Asia-Pacific presents lucrative opportunities for the key players operating in the cell therapy processing market, due to increase in patient awareness toward benefits offered by cell therapy processing, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, rise in healthcare reforms, and technological advancements in cell therapy processing. The countries in this region are highly populated, with China being the first and India the second most populated countries. Therefore, the region possesses high growth potential owing to presence of huge patient base, which is expected to boost the growth of the Asia-Pacific cell therapy processing market. In addition, rise in demand for cell therapy processing, and presence of high population base incomes contribute toward the growth of the market. In addition, increase in research and development expenditure and surge in usage of cell therapy processing products augment the growth of the market. Furthermore, surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the cell therapy processing market in the region.
The key players profiled in this report include Cell Therapies Pty Ltd, Invitrx Inc., Lonza Ltd, Merck & Co., Inc. (FloDesign Sonics), NantWorks, LLC, Neurogeneration, Inc., Novartis AG, Plasticell Ltd., Regeneus Ltd, and StemGenex, Inc.
Key Market Segments:
By Offering Type
U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. In Vitro Diagnostics Market (By Product: Reagents, Instruments; By Technology: Immunoassay, Molecular Diagnostics; By Application: Infectious Diseases, Diabetes, Oncology, Cardiology; By End User: Hospitals, Laboratories, Home-care, Others) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. Clinical Trials Market (By Phase: Phase I, II, III, IV; By Study Design: Interventional, Observational; By Indication: Oncology, Diabetes) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Compounding Pharmacies Market (By Therapeutic Area: Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements; By Product: Oral, Liquid Preparations, Topical, Rectal, Others; By Application: Pediatric, Adult, Geriatric, Veterinary; By Compounding Type: PIA, CUPM, PDA; By Sterility: Sterile, Non-sterile; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...
Optical Imaging Systems Market (By Technology: Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy; By Product: Imaging Systems, Optical Imaging Software, Illumination Systems, Others; By Application: Pathological, Intraoperative; By End-use Outlook; By Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...